PMID: 5469787Sep 1, 1970Paper

Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man

Journal of Pharmaceutical Sciences
R A O'Reilly, G Levy

Abstract

No abstract listed.

Citations

Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·B Hüthwohl, E Jähnchen
Jan 1, 1977·European Journal of Clinical Pharmacology·S Husted, F Andreasen
Jul 1, 1987·European Journal of Drug Metabolism and Pharmacokinetics·C TesseromatisH Kurz
Mar 1, 1987·Current Problems in Cardiology·A C Cuetter, V J Ferrans
Sep 2, 1971·The New England Journal of Medicine·J K Weser, E M Sellers
Nov 1, 1975·The Journal of Pharmacy and Pharmacology·K A Bachmann, A M Burkman
Mar 1, 1980·The Journal of Clinical Investigation·R A O'ReillyW Howald
Jan 1, 1981·Pharmacology & Therapeutics·L Aarons
May 4, 2007·Periodontology 2000·Pamela J Sims, Kevin M Sims
Jul 1, 1978·International Journal of Bio-medical Computing·F DarvasP Szeredi
Jul 1, 1971·Journal of Pharmaceutical Sciences·T L Benney, W E Hamlin
Nov 26, 1973·Annals of the New York Academy of Sciences·P T SchoenemannF J Bullock
Nov 26, 1973·Annals of the New York Academy of Sciences·R A O'Reilly
Nov 1, 1991·Journal of Dairy Science·P S MillerR L Baldwin
Dec 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·W Schmidt, E Jähnchen
Jan 1, 1971·Acta Pharmacologica Et Toxicologica·G Levy
Jul 1, 1985·Drug Intelligence & Clinical Pharmacy·R S RhodesC D Sintek

Related Concepts

Blood Coagulation
Drug Augmentation
Fenilbutazon
Thrombotest
Receptors, Drug
Gen-Warfarin

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.